LiverSource »  Research »  Clinical Research »  Clinical Trials for Liver Disease
Related Programs
Department of Surgery Websites

Make a Gift

A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.

How you can help »
LiverSource »  Research »  Clinical Research »  Clinical Trials for Liver Disease

Clinical Trials for Liver Disease

UCSF has a thriving clinical research program and offers patients a broad portfolio of clinical trials for liver disease. These are led by Principal Investigators (PI) supported by a team of trial coordinators, clinical research nurses and other staff.

   Also show trials not enrolling patients
Select by Type: 

Biliary Atresia

Biliary Atresia Research Consortium
Study ID: BARC-PROBE
Principal Investigator:
Philip Rosenthal, M.D.
Enrolling patients

Hepatocellular Carcinoma (Primary Liver Cancer)

A Study of LY2157299 in Patients With Hepatocellular Carcinoma
Study ID: UCSF-11452
Principal Investigator:
R. Kate (Katie) Kelley, M.D.
Enrolling patients
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Study ID: ECOG-E1208
Principal Investigator:
Alan P. Venook, M.D.
Enrolling patients
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Study ID: CALGB-80802
Principal Investigator:
Alan P. Venook, M.D.
Enrolling patients
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Study ID: UCSF-09455
Principal Investigator:
R. Kate (Katie) Kelley, M.D.
Enrolling patients
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Study ID: UCSF-08451-A
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients

Liver Metastases

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients

Liver Transplant

Adult-to-Adult Living Donor Liver Transplantation Study
Study ID: A2ALL Deux
Principal Investigator:
Chris E. Freise, M.D.
Enrolling patients
Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients
Study ID: AEB
Principal Investigator:
John P. Roberts, M.D.
Enrolling patients
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Study ID: AWISH
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Enrolling patients

Solid Tumor

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Study ID: UCSF-11993
Principal Investigator:
Hope Rugo, M.D.
Enrolling patients
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Study ID: UCSF-11996
Principal Investigator:
Hope Rugo, M.D.
Not yet enrolling
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Study ID: UCSF-10998
Principal Investigator:
A. Jo Chien, M.D.
Enrolling patients
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Study ID: UCSF-09991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Study ID: UCSF-11991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Study ID: UCSF-11995
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Study ID: UCSF-11995
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Study ID: UCSF-10993
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
X